Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic
1 other identifier
observational
762
0 countries
N/A
Brief Summary
The aim of the study is to find out prevalence of diabetic macular edema (DME) in patients with diabetes mellitus in Slovak Republic.The outcome of the project will be epidemiology survey, prevalence of wet form of Diabetic Macular Edema in relation to duration of diabetes, type of diabetes, treatment (insulin vs. OAD or combination) etc. and identification of prognostic factors leading to development of DME.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2012
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 11, 2014
CompletedFirst Posted
Study publicly available on registry
February 14, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 14, 2014
February 1, 2014
2.8 years
February 11, 2014
February 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Diabetic Macular Edema or clinically significant Diabetic Macular Edema
Image of fundus taken in NIED securely sent via internet and electronic Clinical Report Form (eCRF) to ophthalmology reading center to assess stage and severity of potential retina damage, feedback to NIED within the stay of screened individual essential for further disease management
Patients screened during hospitalization in National Institute of Endocrinology and Diabetology (NIED), usually in 10 days
Secondary Outcomes (5)
Patient´s structure with DME and clinically significant DME in terms of demography and anamnesis of diabetes
Patients screened during hospitalization in NIED, usually in 10 days
Range of visual deterioration and occurence of blindness in relation to duration of diabetes
Patients screened during hospitalization in NIED, usually in 10 days
Prognostic factors, which determine the occurence of DME using explorative analysis
Patients screened during hospitalization in NIED, usually in 10 days
Range of visual deterioration and occurence of blindness in relation to type of diabetes
Patients screened during hospitalization in NIED, usually in 10 days
Range of visual deterioration and occurence of blindness in relation to general treatment (insulin vs. OAD or combination therapy)
Patients screened during hospitalization in NIED, usually in 10 days
Eligibility Criteria
Adults regularly examined in National Institute of Endocrinology and Diabetology (NIED) for their severity and complications of diabetes will undergo a screening procedure using fundus camera to assess the back of the eye (fundus examination).
You may qualify if:
- Adults ≥18 years treated in National Institute of Endocrinology and Diabetology
- Patients diagnosed with Diabetes mellitus type I and type 2 respectively
- Presence of Diabetes ≥10 years or patients with suspected visual impairment (duration of diabetes \<10 years)
- Signed patient´s information and informed content
You may not qualify if:
- Non-compliant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emil Martinkalead
- Novartis Slovakia, s.r.o.collaborator
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marta Ondrejkova, MD
II. Eye Clinic SZU of F.D.Roosevelt Hospital, Banska Bystrica
- STUDY CHAIR
Monika Gajdosova, MD
Oftal, s.r.o. Specialized Hospital for Ophthalmology, Zvolen
- PRINCIPAL INVESTIGATOR
Emil Martinka, MD
Department of Diabetology of National Institute for Endocrinology and Diabetology, Lubochna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Diabetology Department
Study Record Dates
First Submitted
February 11, 2014
First Posted
February 14, 2014
Study Start
December 1, 2012
Primary Completion
September 1, 2015
Study Completion
December 1, 2015
Last Updated
February 14, 2014
Record last verified: 2014-02